BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10616580)

  • 1. Platinum distribution in malignant glioma following intraoperative intravenous infusion of carboplatin.
    Whittle IR; Malcolm G; Jodrell DI; Reid M
    Br J Neurosurg; 1999 Apr; 13(2):132-7. PubMed ID: 10616580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
    Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
    J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
    Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
    J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and dose optimisation of carboplatin.
    Duffull SB; Robinson BA
    Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
    Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C; Matsumoto K; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
    Galanis E; Buckner JC; Maurer MJ; Reid JM; Kuffel MJ; Ames MM; Scheithauer BW; Hammack JE; Pipoly G; Kuross SA
    Invest New Drugs; 2005 Oct; 23(5):495-503. PubMed ID: 16133802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
    Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
    Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
    Emerich DF; Snodgrass P; Dean R; Agostino M; Hasler B; Pink M; Xiong H; Kim BS; Bartus RT
    Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve.
    Ghazal-Aswad S; Calvert AH; Newell DR
    Cancer Chemother Pharmacol; 1996; 37(5):429-34. PubMed ID: 8599865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma.
    Ford J; Osborn C; Barton T; Bleehen NM
    Eur J Cancer; 1998 Oct; 34(11):1807-11. PubMed ID: 9893673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
    Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT
    Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of carboplatin.
    van der Vijgh WJ
    Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
    Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
    Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
    Smit EF; Willemse PH; Sleijfer DT; Uges DR; Postmus PE; Meijer S; Terheggen PM; Mulder NH; de Vries EG
    J Clin Oncol; 1991 Jan; 9(1):100-10. PubMed ID: 1985158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
    Kigawa J; Minagawa Y; Itamochi H; Kanamori Y; Ishihara H; Terakawa N
    Obstet Gynecol; 1995 Aug; 86(2):265-8. PubMed ID: 7617358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.